ICR Westwicke is an IPO advisory, capital markets advisory, and strategic communications firm. We provide integrated investor relations, public relations, and independent capital markets advice to small and mid-cap healthcare companies.
We work with private and public healthcare companies to help position their story properly with all critical stakeholders and to develop value-added strategies to build brand awareness, corporate reputation and enhance equity market value. Through an integrated approach, we provide a one-stop-shop for the full spectrum of communications needs across the entire corporate lifecycle from early stage start-up to mature public company.
Our background is unique. Our investor relations partners all come directly from Wall Street as former sell-side research analysts, institutional salesmen, investment bankers, equity capital markets professionals, buy-side analysts and portfolio managers, while our public relations team are former agency veterans, corporate communications executives and journalists.
Learn more
Latest Blog Posts
-
November 18th, 2021
What the COVID-19 Pandemic Taught Us About the Power of Words
As public health officials discuss whether to call subsequent COVID-19 vaccinations “boosters,” fearing it gives the impression that previous inoculations weren’t effective—some preferred “third dose” or “final dose”—chalk it up to yet another debate about words and nomenclature related to the worst global pandemic in a century.
-
November 10th, 2021
Tailor Your Investor Meetings to the Audience and Timeframe
You spend considerable time creating a professional investor presentation that tells a comprehensive story of your company. Yet aside from the analyst/investor due diligence meeting, few opportunities exist for you to deliver the entire presentation from start-to-finish. How, then, can you tailor your presentation to the time and opportunities at hand?
-
November 1st, 2021
The Current and Future State of Biotech Financing
In the face of a global pandemic, capital markets have (understandably) seen unprecedented behavior over the past two years. With vaccines, rapid testing, and medical research at center stage of every news outlet and publication, the biotech sector has been especially active. There have been major shifts in both buy- and sell-side activities, leaving many […]
